Kronox Lab's annual results are a study in flatness
FY26 revenue was ₹101.22 crore, barely above last year's ₹100.19 crore. Net profit rose to ₹27.66 crore. The dividend is unchanged.
What's new
- FY26 revenue grew 1% to ₹101.22 crore from ₹100.19 crore.
- Net profit increased to ₹27.66 crore from ₹25.47 crore.
- Board recommended a final dividend of ₹0.50 per share.
Why this matters
Revenue essentially stood still for a full fiscal year. For a nano-cap with a ₹488 crore market cap, that's stagnation. The profit growth is a positive, but the top line shows no momentum.
What we're watching
- Any strategic commentary from management on breaking out of the ₹100 crore revenue range.
- Whether the profit growth is sustained through margin improvement or is a one-off.
- If the flat top line prompts a strategic pivot in FY27.
The full read
Kronox Lab's FY26 numbers are a picture of stasis. Revenue was ₹101.22 crore. The year before, it was ₹100.19 crore. That's a 1% increase over a full fiscal year. Net profit improved to ₹27.66 crore from ₹25.47 crore. A solid gain on the bottom line, but it doesn't mask the flat top line. The dividend stays at ₹0.50 a share. For a ₹488 crore market cap, the scale is small. The auditor's report is clean. Nothing here moves the stock. It's a routine announcement that confirms the business is running in place.
Questions answered
- How did Kronox's FY26 results compare to the prior year?
- Revenue grew 1% to ₹101.22 crore from ₹100.19 crore. Net profit rose to ₹27.66 crore from ₹25.47 crore.
- What is the dividend announcement?
- The board recommended a final dividend of ₹0.50 per share, matching the prior year's payout.
- Was there any surprise in the auditor's report?
- No. The report was unmodified, confirming no accounting irregularities and no deviations from standard reporting.
- Is this a material event for the stock?
- No. The results were widely anticipated and offer no new information. The filing confirms the status quo.